GPD2 and prostate carcinoma: Notably, recent research has shown that mGPDH can modulate cell growth in thyroid cancer8 and reactive oxygen species (ROS) generation in the oxidative stress‐induced progression of prostate cancer and that mGPDH functions as a crucial regulator of mitochondrial oxidative stress.10, 11, 12